Cohen & Steers, Inc. (New York)

  • Market Cap: Small Cap
  • Industry: Capital Markets
  • ISIN: US19247A1007
USD
62.65
0.25 (0.4%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Cohen & Steers, Inc. (New York) stock-summary
stock-summary
Cohen & Steers, Inc. (New York)
Capital Markets
Cohen & Steers, Inc. (CNS) is a holding company. The Company is an investment manager with a focus on liquid real assets, including real estate securities, listed infrastructure, commodities and natural resource equities, as well as preferred securities and other income solutions. The Company serves institutional and individual investors. The Company manages three types of investment vehicles: institutional accounts, open-end funds and closed-end funds. The Company also provides services in connection with model-based strategies (MBS) accounts. In addition, the Company provides several services in connection with assets held by unit investment trusts (UITs). As a portfolio consultant to a number of UITs, the Company constructs a portfolio of securities that suit the investment objective of the UIT. The Company also provides ongoing portfolio monitoring services and provides a license to certain firms to use its name in connection with certain of their investment products.
Company Coordinates stock-summary
Company Details
280 Park Ave Fl 10 , NEW YORK NY : 10017-1220
stock-summary
Tel: 1 212 83232321 212 7969353
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 70 Schemes (36.56%)

Foreign Institutions

Held by 103 Foreign Institutions (3.88%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Martin Cohen
Chairman of the Board
Mr. Joseph Harvey
President, Director
Mr. Robert Steers
Chief Executive Officer, Director
Dr. Reena Aggarwal
Independent Director
Mr. Frank Connor
Independent Director
Mr. Peter Rhein
Independent Director
Mr. Richard Simon
Independent Director
Ms. Dasha Smith
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
136 Million
(Quarterly Results - Jun 2025)
Net Profit:
42 Million
stock-summary
Industry

Capital Markets

stock-summary
Market cap

USD 4,105 Million (Small Cap)

stock-summary
P/E

28.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

146.36%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

30.67%

stock-summary
Price to Book

7.77